Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-0583-2016

Drug recall · January 27, 2016

Bevacizumab 2 mg/0.08 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal recall

Why: Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes for intravitreal use.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Bevacizumab 2 mg/0.08 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal, Rx -- Pine Pharmaceuticals, 100 Colvin Woods Pkwy Suite 300, Tonawanda, NY 14150.

Lots / codes

Lot #: 1837@2, exp. 1/17/2016; 1646@6, exp. 12/20/2015

Quantity
N/A
Company
Pine Pharmaceuticals, LLC, Tonawanda, NY
Distribution
Nationwide and Puerto Rico
Initiated
November 4, 2015 · Voluntary: Firm initiated
Classified
January 20, 2016
Reported
January 27, 2016
Ended
March 22, 2017
How notified
Letter

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.